NCT06964620View on ClinicalTrials.gov

Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

November 24, 2027

Study Completion Date

December 25, 2027

Conditions
Diabetes Mellitus, Type 2Impaired Glucose Tolerance
Interventions
DRUG

Sanggua tablets

Patients will continue their background medications and receive Sang Gua tablets, twice daily (bid).

DRUG

Placebo

Patients will continue their background medications and receive placebo, twice daily (bid).

Trial Locations (1)

430030

RECRUITING

Tongji Hospital, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER